MAPK7 and adenocarcinoma: Human cervical (HeLa), endometrial (Ishikawa) and pancreatic (MiaPaCa-2) adenocarcinoma cell lines were serum starved and treated with the ERK5 inhibitor JWG-071 for different times, and LC3-I/LC3-II levels were evaluated by immunoblotting.